nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—embryo—muscle cancer	0.0297	0.127	CbGeAlD
Azacitidine—DNMT1—Vinblastine—Vincristine—muscle cancer	0.0196	1	CbGdCrCtD
Azacitidine—DNMT1—embryo—muscle cancer	0.0179	0.0769	CbGeAlD
Azacitidine—DNMT3A—tendon—muscle cancer	0.0175	0.0751	CbGeAlD
Azacitidine—CDA—tendon—muscle cancer	0.0166	0.071	CbGeAlD
Azacitidine—DNMT3A—vagina—muscle cancer	0.0163	0.0697	CbGeAlD
Azacitidine—CDA—bone marrow—muscle cancer	0.016	0.0688	CbGeAlD
Azacitidine—CDA—vagina—muscle cancer	0.0154	0.0659	CbGeAlD
Azacitidine—DNMT3A—head—muscle cancer	0.015	0.0644	CbGeAlD
Azacitidine—DNMT3A—testis—muscle cancer	0.0145	0.0622	CbGeAlD
Azacitidine—CDA—testis—muscle cancer	0.0137	0.0588	CbGeAlD
Azacitidine—DNMT1—cardiac atrium—muscle cancer	0.0122	0.0521	CbGeAlD
Azacitidine—DNMT1—tendon—muscle cancer	0.0106	0.0454	CbGeAlD
Azacitidine—DNMT1—bone marrow—muscle cancer	0.0103	0.044	CbGeAlD
Azacitidine—DNMT1—vagina—muscle cancer	0.00984	0.0422	CbGeAlD
Azacitidine—DNMT1—head—muscle cancer	0.00909	0.0389	CbGeAlD
Azacitidine—DNMT1—testis—muscle cancer	0.00878	0.0376	CbGeAlD
Azacitidine—Anorexia—Vincristine—muscle cancer	0.00123	0.00164	CcSEcCtD
Azacitidine—Hepatic failure—Doxorubicin—muscle cancer	0.00122	0.00164	CcSEcCtD
Azacitidine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00121	0.00162	CcSEcCtD
Azacitidine—Hypotension—Vincristine—muscle cancer	0.0012	0.00161	CcSEcCtD
Azacitidine—Feeling abnormal—Dactinomycin—muscle cancer	0.00119	0.00159	CcSEcCtD
Azacitidine—Ill-defined disorder—Etoposide—muscle cancer	0.00118	0.00159	CcSEcCtD
Azacitidine—Anaemia—Etoposide—muscle cancer	0.00118	0.00158	CcSEcCtD
Azacitidine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00118	0.00158	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00117	0.00157	CcSEcCtD
Azacitidine—Insomnia—Vincristine—muscle cancer	0.00116	0.00156	CcSEcCtD
Azacitidine—Malaise—Etoposide—muscle cancer	0.00115	0.00154	CcSEcCtD
Azacitidine—Leukopenia—Etoposide—muscle cancer	0.00114	0.00153	CcSEcCtD
Azacitidine—Purpura—Doxorubicin—muscle cancer	0.00114	0.00153	CcSEcCtD
Azacitidine—Abdominal pain—Dactinomycin—muscle cancer	0.00114	0.00152	CcSEcCtD
Azacitidine—Body temperature increased—Dactinomycin—muscle cancer	0.00114	0.00152	CcSEcCtD
Azacitidine—Cardiac failure—Doxorubicin—muscle cancer	0.00113	0.00151	CcSEcCtD
Azacitidine—Loss of consciousness—Etoposide—muscle cancer	0.00112	0.0015	CcSEcCtD
Azacitidine—Lethargy—Doxorubicin—muscle cancer	0.00112	0.0015	CcSEcCtD
Azacitidine—Decreased appetite—Vincristine—muscle cancer	0.00112	0.0015	CcSEcCtD
Azacitidine—Cough—Etoposide—muscle cancer	0.00111	0.00149	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00111	0.00149	CcSEcCtD
Azacitidine—Fatigue—Vincristine—muscle cancer	0.00111	0.00148	CcSEcCtD
Azacitidine—Convulsion—Etoposide—muscle cancer	0.00111	0.00148	CcSEcCtD
Azacitidine—Hypertension—Etoposide—muscle cancer	0.0011	0.00148	CcSEcCtD
Azacitidine—Constipation—Vincristine—muscle cancer	0.0011	0.00147	CcSEcCtD
Azacitidine—Pain—Vincristine—muscle cancer	0.0011	0.00147	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.0011	0.00147	CcSEcCtD
Azacitidine—Pain in extremity—Doxorubicin—muscle cancer	0.0011	0.00147	CcSEcCtD
Azacitidine—Chest pain—Etoposide—muscle cancer	0.00109	0.00146	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00108	0.00145	CcSEcCtD
Azacitidine—Discomfort—Etoposide—muscle cancer	0.00107	0.00144	CcSEcCtD
Azacitidine—Hypersensitivity—Dactinomycin—muscle cancer	0.00106	0.00142	CcSEcCtD
Azacitidine—Gastrointestinal pain—Vincristine—muscle cancer	0.00105	0.00141	CcSEcCtD
Azacitidine—Confusional state—Etoposide—muscle cancer	0.00105	0.00141	CcSEcCtD
Azacitidine—Pancytopenia—Methotrexate—muscle cancer	0.00104	0.0014	CcSEcCtD
Azacitidine—Anaphylactic shock—Etoposide—muscle cancer	0.00104	0.0014	CcSEcCtD
Azacitidine—Infection—Etoposide—muscle cancer	0.00104	0.00139	CcSEcCtD
Azacitidine—Asthenia—Dactinomycin—muscle cancer	0.00103	0.00138	CcSEcCtD
Azacitidine—Dysuria—Methotrexate—muscle cancer	0.00103	0.00137	CcSEcCtD
Azacitidine—Neutropenia—Methotrexate—muscle cancer	0.00103	0.00137	CcSEcCtD
Azacitidine—Dehydration—Doxorubicin—muscle cancer	0.00102	0.00137	CcSEcCtD
Azacitidine—Thrombocytopenia—Etoposide—muscle cancer	0.00102	0.00137	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00102	0.00137	CcSEcCtD
Azacitidine—Tachycardia—Etoposide—muscle cancer	0.00102	0.00136	CcSEcCtD
Azacitidine—Abdominal pain—Vincristine—muscle cancer	0.00102	0.00136	CcSEcCtD
Azacitidine—Body temperature increased—Vincristine—muscle cancer	0.00102	0.00136	CcSEcCtD
Azacitidine—Skin disorder—Etoposide—muscle cancer	0.00101	0.00136	CcSEcCtD
Azacitidine—Dry skin—Doxorubicin—muscle cancer	0.00101	0.00135	CcSEcCtD
Azacitidine—Hyperhidrosis—Etoposide—muscle cancer	0.00101	0.00135	CcSEcCtD
Azacitidine—Abdominal pain upper—Doxorubicin—muscle cancer	0.001	0.00134	CcSEcCtD
Azacitidine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.001	0.00134	CcSEcCtD
Azacitidine—Hypokalaemia—Doxorubicin—muscle cancer	0.001	0.00134	CcSEcCtD
Azacitidine—Anorexia—Etoposide—muscle cancer	0.000993	0.00133	CcSEcCtD
Azacitidine—Diarrhoea—Dactinomycin—muscle cancer	0.000985	0.00132	CcSEcCtD
Azacitidine—Pneumonia—Methotrexate—muscle cancer	0.000984	0.00132	CcSEcCtD
Azacitidine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000983	0.00132	CcSEcCtD
Azacitidine—Infestation NOS—Methotrexate—muscle cancer	0.000979	0.00131	CcSEcCtD
Azacitidine—Infestation—Methotrexate—muscle cancer	0.000979	0.00131	CcSEcCtD
Azacitidine—Depression—Methotrexate—muscle cancer	0.000976	0.00131	CcSEcCtD
Azacitidine—Hypotension—Etoposide—muscle cancer	0.000974	0.0013	CcSEcCtD
Azacitidine—Muscular weakness—Doxorubicin—muscle cancer	0.00097	0.0013	CcSEcCtD
Azacitidine—Renal failure—Methotrexate—muscle cancer	0.000962	0.00129	CcSEcCtD
Azacitidine—Abdominal distension—Doxorubicin—muscle cancer	0.000957	0.00128	CcSEcCtD
Azacitidine—Stomatitis—Methotrexate—muscle cancer	0.000954	0.00128	CcSEcCtD
Azacitidine—Dysphagia—Doxorubicin—muscle cancer	0.000951	0.00127	CcSEcCtD
Azacitidine—Hypersensitivity—Vincristine—muscle cancer	0.000948	0.00127	CcSEcCtD
Azacitidine—Haematuria—Methotrexate—muscle cancer	0.000933	0.00125	CcSEcCtD
Azacitidine—Dyspnoea—Etoposide—muscle cancer	0.000929	0.00124	CcSEcCtD
Azacitidine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000926	0.00124	CcSEcCtD
Azacitidine—Epistaxis—Methotrexate—muscle cancer	0.000923	0.00124	CcSEcCtD
Azacitidine—Asthenia—Vincristine—muscle cancer	0.000923	0.00124	CcSEcCtD
Azacitidine—Vomiting—Dactinomycin—muscle cancer	0.000916	0.00123	CcSEcCtD
Azacitidine—Bronchitis—Doxorubicin—muscle cancer	0.000914	0.00122	CcSEcCtD
Azacitidine—Agranulocytosis—Methotrexate—muscle cancer	0.000913	0.00122	CcSEcCtD
Azacitidine—Rash—Dactinomycin—muscle cancer	0.000908	0.00122	CcSEcCtD
Azacitidine—Decreased appetite—Etoposide—muscle cancer	0.000906	0.00121	CcSEcCtD
Azacitidine—Pancytopenia—Doxorubicin—muscle cancer	0.000903	0.00121	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Etoposide—muscle cancer	0.0009	0.0012	CcSEcCtD
Azacitidine—Fatigue—Etoposide—muscle cancer	0.000899	0.0012	CcSEcCtD
Azacitidine—Pain—Etoposide—muscle cancer	0.000891	0.00119	CcSEcCtD
Azacitidine—Constipation—Etoposide—muscle cancer	0.000891	0.00119	CcSEcCtD
Azacitidine—Dysuria—Doxorubicin—muscle cancer	0.000889	0.00119	CcSEcCtD
Azacitidine—Neutropenia—Doxorubicin—muscle cancer	0.000889	0.00119	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000883	0.00118	CcSEcCtD
Azacitidine—Haemoglobin—Methotrexate—muscle cancer	0.000883	0.00118	CcSEcCtD
Azacitidine—Diarrhoea—Vincristine—muscle cancer	0.00088	0.00118	CcSEcCtD
Azacitidine—Haemorrhage—Methotrexate—muscle cancer	0.000879	0.00118	CcSEcCtD
Azacitidine—Pharyngitis—Methotrexate—muscle cancer	0.000872	0.00117	CcSEcCtD
Azacitidine—Urinary tract disorder—Methotrexate—muscle cancer	0.000868	0.00116	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—muscle cancer	0.000861	0.00115	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—muscle cancer	0.00086	0.00115	CcSEcCtD
Azacitidine—Feeling abnormal—Etoposide—muscle cancer	0.000859	0.00115	CcSEcCtD
Azacitidine—Nausea—Dactinomycin—muscle cancer	0.000855	0.00115	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—muscle cancer	0.000852	0.00114	CcSEcCtD
Azacitidine—Gastrointestinal pain—Etoposide—muscle cancer	0.000852	0.00114	CcSEcCtD
Azacitidine—Dizziness—Vincristine—muscle cancer	0.000851	0.00114	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—muscle cancer	0.000848	0.00113	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—muscle cancer	0.000848	0.00113	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—muscle cancer	0.000833	0.00112	CcSEcCtD
Azacitidine—Urticaria—Etoposide—muscle cancer	0.000828	0.00111	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—muscle cancer	0.000826	0.00111	CcSEcCtD
Azacitidine—Abdominal pain—Etoposide—muscle cancer	0.000824	0.0011	CcSEcCtD
Azacitidine—Body temperature increased—Etoposide—muscle cancer	0.000824	0.0011	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—muscle cancer	0.000824	0.0011	CcSEcCtD
Azacitidine—Eye disorder—Methotrexate—muscle cancer	0.000821	0.0011	CcSEcCtD
Azacitidine—Vomiting—Vincristine—muscle cancer	0.000818	0.0011	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—muscle cancer	0.000815	0.00109	CcSEcCtD
Azacitidine—Rash—Vincristine—muscle cancer	0.000811	0.00109	CcSEcCtD
Azacitidine—Dermatitis—Vincristine—muscle cancer	0.00081	0.00108	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—muscle cancer	0.000808	0.00108	CcSEcCtD
Azacitidine—Headache—Vincristine—muscle cancer	0.000806	0.00108	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000802	0.00107	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—muscle cancer	0.000799	0.00107	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—muscle cancer	0.000797	0.00107	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—muscle cancer	0.000795	0.00106	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—muscle cancer	0.000794	0.00106	CcSEcCtD
Azacitidine—Mediastinal disorder—Methotrexate—muscle cancer	0.000792	0.00106	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—muscle cancer	0.000791	0.00106	CcSEcCtD
Azacitidine—Chills—Methotrexate—muscle cancer	0.000788	0.00106	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—muscle cancer	0.000776	0.00104	CcSEcCtD
Azacitidine—Mental disorder—Methotrexate—muscle cancer	0.00077	0.00103	CcSEcCtD
Azacitidine—Hypersensitivity—Etoposide—muscle cancer	0.000768	0.00103	CcSEcCtD
Azacitidine—Erythema—Methotrexate—muscle cancer	0.000765	0.00102	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—muscle cancer	0.000765	0.00102	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—muscle cancer	0.000765	0.00102	CcSEcCtD
Azacitidine—Nausea—Vincristine—muscle cancer	0.000764	0.00102	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—muscle cancer	0.000763	0.00102	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—muscle cancer	0.000761	0.00102	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000757	0.00101	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—muscle cancer	0.000755	0.00101	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000751	0.00101	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—muscle cancer	0.00075	0.001	CcSEcCtD
Azacitidine—Asthenia—Etoposide—muscle cancer	0.000748	0.001	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000748	0.001	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—muscle cancer	0.000746	0.000998	CcSEcCtD
Azacitidine—Back pain—Methotrexate—muscle cancer	0.00074	0.00099	CcSEcCtD
Azacitidine—Pruritus—Etoposide—muscle cancer	0.000737	0.000987	CcSEcCtD
Azacitidine—Diarrhoea—Etoposide—muscle cancer	0.000713	0.000955	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—muscle cancer	0.000711	0.000952	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—muscle cancer	0.00071	0.00095	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—muscle cancer	0.000707	0.000946	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—muscle cancer	0.000706	0.000945	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—muscle cancer	0.00069	0.000924	CcSEcCtD
Azacitidine—Malaise—Methotrexate—muscle cancer	0.00069	0.000923	CcSEcCtD
Azacitidine—Dizziness—Etoposide—muscle cancer	0.000689	0.000923	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—muscle cancer	0.000687	0.00092	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000686	0.000918	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—muscle cancer	0.000685	0.000917	CcSEcCtD
Azacitidine—Chills—Doxorubicin—muscle cancer	0.000683	0.000914	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—muscle cancer	0.000672	0.0009	CcSEcCtD
Azacitidine—Cough—Methotrexate—muscle cancer	0.000667	0.000894	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—muscle cancer	0.000667	0.000892	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—muscle cancer	0.000663	0.000887	CcSEcCtD
Azacitidine—Vomiting—Etoposide—muscle cancer	0.000663	0.000887	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—muscle cancer	0.000662	0.000887	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—muscle cancer	0.000662	0.000887	CcSEcCtD
Azacitidine—Rash—Etoposide—muscle cancer	0.000657	0.00088	CcSEcCtD
Azacitidine—Dermatitis—Etoposide—muscle cancer	0.000657	0.000879	CcSEcCtD
Azacitidine—Headache—Etoposide—muscle cancer	0.000653	0.000874	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—muscle cancer	0.000651	0.000872	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—muscle cancer	0.000651	0.000872	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—muscle cancer	0.000651	0.000872	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000647	0.000866	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—muscle cancer	0.000643	0.000861	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—muscle cancer	0.000641	0.000858	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—muscle cancer	0.000637	0.000852	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—muscle cancer	0.000629	0.000843	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—muscle cancer	0.000624	0.000836	CcSEcCtD
Azacitidine—Infection—Methotrexate—muscle cancer	0.00062	0.00083	CcSEcCtD
Azacitidine—Nausea—Etoposide—muscle cancer	0.000619	0.000829	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000615	0.000823	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—muscle cancer	0.000612	0.00082	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—muscle cancer	0.000612	0.000819	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—muscle cancer	0.000611	0.000818	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—muscle cancer	0.000606	0.000812	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—muscle cancer	0.000603	0.000808	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—muscle cancer	0.000597	0.0008	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—muscle cancer	0.000595	0.000797	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—muscle cancer	0.000594	0.000795	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—muscle cancer	0.000593	0.000794	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—muscle cancer	0.000583	0.000781	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—muscle cancer	0.000582	0.000779	CcSEcCtD
Azacitidine—Cough—Doxorubicin—muscle cancer	0.000578	0.000774	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—muscle cancer	0.000574	0.000768	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—muscle cancer	0.000572	0.000765	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000569	0.000761	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—muscle cancer	0.000565	0.000756	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—muscle cancer	0.000564	0.000755	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—muscle cancer	0.000564	0.000755	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—muscle cancer	0.000564	0.000755	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—muscle cancer	0.000562	0.000752	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00056	0.00075	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—muscle cancer	0.000557	0.000746	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—muscle cancer	0.000557	0.000745	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—muscle cancer	0.00055	0.000736	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—muscle cancer	0.000545	0.00073	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—muscle cancer	0.000543	0.000726	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000541	0.000724	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—muscle cancer	0.000541	0.000724	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000539	0.000721	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—muscle cancer	0.000538	0.00072	CcSEcCtD
Azacitidine—Infection—Doxorubicin—muscle cancer	0.000537	0.000719	CcSEcCtD
Azacitidine—Pain—Methotrexate—muscle cancer	0.000534	0.000715	CcSEcCtD
Azacitidine—Shock—Doxorubicin—muscle cancer	0.000532	0.000712	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—muscle cancer	0.00053	0.00071	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000529	0.000709	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—muscle cancer	0.000528	0.000706	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—muscle cancer	0.000525	0.000703	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000523	0.0007	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—muscle cancer	0.000515	0.00069	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—muscle cancer	0.000514	0.000689	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00051	0.000683	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—muscle cancer	0.000505	0.000676	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—muscle cancer	0.000496	0.000664	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—muscle cancer	0.000493	0.000661	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—muscle cancer	0.000493	0.000661	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000492	0.000659	CcSEcCtD
Azacitidine—Insomnia—Doxorubicin—muscle cancer	0.000489	0.000654	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—muscle cancer	0.000482	0.000645	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—muscle cancer	0.000476	0.000637	CcSEcCtD
Azacitidine—Decreased appetite—Doxorubicin—muscle cancer	0.00047	0.000629	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000467	0.000625	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—muscle cancer	0.000466	0.000624	CcSEcCtD
Azacitidine—Pain—Doxorubicin—muscle cancer	0.000462	0.000619	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—muscle cancer	0.000462	0.000619	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—muscle cancer	0.00046	0.000616	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—muscle cancer	0.000448	0.0006	CcSEcCtD
Azacitidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000445	0.000596	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000442	0.000592	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—muscle cancer	0.000442	0.000591	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—muscle cancer	0.000429	0.000575	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—muscle cancer	0.000427	0.000572	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—muscle cancer	0.000427	0.000572	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—muscle cancer	0.000427	0.000572	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—muscle cancer	0.000413	0.000553	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—muscle cancer	0.000398	0.000533	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—muscle cancer	0.000397	0.000531	CcSEcCtD
Azacitidine—Rash—Methotrexate—muscle cancer	0.000394	0.000527	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—muscle cancer	0.000393	0.000526	CcSEcCtD
Azacitidine—Headache—Methotrexate—muscle cancer	0.000391	0.000524	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—muscle cancer	0.000388	0.000519	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—muscle cancer	0.000382	0.000512	CcSEcCtD
Azacitidine—Nausea—Methotrexate—muscle cancer	0.000371	0.000496	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—muscle cancer	0.00037	0.000495	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—muscle cancer	0.000357	0.000479	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—muscle cancer	0.000344	0.00046	CcSEcCtD
Azacitidine—Rash—Doxorubicin—muscle cancer	0.000341	0.000456	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—muscle cancer	0.000341	0.000456	CcSEcCtD
Azacitidine—Headache—Doxorubicin—muscle cancer	0.000339	0.000453	CcSEcCtD
Azacitidine—Nausea—Doxorubicin—muscle cancer	0.000321	0.00043	CcSEcCtD
